top of page

Sumitomo Chemical and Sumitomo Pharmaceutical: Part II - CiRA, Dr. Yamanaka, and the undisclosed history of image duplication concerns

Gotham City Research LLC
Aug 6
1 min read

Updated: Aug 19

SUMMARY

  • Sumitomo Pharma targets 350 billion JPY in iPs revenue, including from Amchepry

  • The Center for iPS Cell Research & Application (CiRA) is SP’s research partner

  • CIRA is IPS cells supplier for the Amchepry trials, conducts the trials + research

  • CiRA is paid by Sumitomo Pharma, with a relationship since 2011.

  • Sumitomo Pharma is going all-in on CiRA while Takeda recently terminated its 10 year partnership with CiRA.

  • There are two well documented cases of fraud involving CiRa and its founder Shinya Yamanaka, in 2014 and 2018.

  • However, we have discovered 8 additional problematic cases, including 1 research paper where the Amchepry trial’s lead investigator is an author

  • Amchepry depends on the integrity of CiRA, but CiRa is suspect, unreliable.



For the full report:


 
 
 

Recent Posts

See All

66 Comments


rohitkamat0143
5 days ago

Hey, has anyone here tried Bharat Club Login ? I just found out about it and wanted to know how it actually works. Is it easy to use, and does everything run smoothly? Would be great to hear some honest experiences from people who have used it.

Like

Liza Christen
Liza Christen
5 days ago

Many women do not have enough time to visit different offices just to understand a government scheme. Accessible online information can help them learn about the process before taking the next step. Details about eligibility, required ladki bahin yojana kyc paperwork, and available assistance are especially valuable. Regularly reviewed articles can also help readers distinguish current instructions from older information that may no longer apply.

Like

tacones
6 days ago
sandaalit suomi

Like

tacones
6 days ago
sandaletten schweiz

Like

tacones
Oct 24
platform hæle sko

Like

© Gotham City Research LLC

bottom of page